Filters
Survival is worse among patients with advanced BRAFV600 wild-type melanoma than those with BRAFV600-mutant advanced melanoma during the first 10 months following diagnosis due to limited treatment options, according to a Dutch study.
High continuity of care (COC) helps lower medical costs among patients with chronic shoulder pain, a recent study has found.
Chronic baseline prostate inflammation in a negative biopsy is predictive of a lower prostate cancer grade among men with cancer on follow-up 2-year biopsy, a study has shown.
Diets containing carbohydrates, regardless of its amount, may contribute to new-onset hypertension, with minimal risk evident at 50–55 percent carbohydrate intake, a study has found.
Women with gestational diabetes mellitus (GDM) are at risk of developing metabolic syndrome during pregnancy, a study has found. Likewise, this risk is seen in children exposed to GDM in utero.
Hepatotoxicity is common after treatment with onasemnogene abeparvovec for spinal muscular atrophy, a recent study has found. Clinicians should anticipate and be ready to manage such adverse events, and be aware of any potential underlying conditions that could aggravate them.
While more and more COVID-19 vaccines are getting rolled out globally, the world is also seeing new variants of SARS-CoV-2 emerging. How effective will the vaccines work against these new variants is largely unknown. Billions worldwide are watching closely and bracing themselves on how this might unfold.
Neck circumference aids in the detection of metabolic syndrome in adults, a study reports.
The effectiveness of programmed cell death protein 1 or its ligand (L1) inhibitors is similar as regards time to initiation of third therapy or death and overall survival in patients with platinum refractory locally advanced/unresectable or metastatic urothelial carcinoma, a recent study has shown.
Supplementation with pancreatic enzymes results in symptomatic recovery in hepatocellular carcinoma (HCC), as shown in a study that validated the association between malabsorption (MA) and pancreatic insufficiency (PI) in 10 percent of sorafenib-treated patients.
